Therapeutic Drug Monitoring of Brodalumab in Psoriasis Patients (BIOLOPTIM-BRO)

Clinical trial NCT04080635 · RECRUITING

Trial details

NCT number: NCT04080635
Sponsor: University Hospital, Ghent
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Psoriasis Vulgaris

Start date: 2018-12-14
Primary completion: 2024-12-31
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.